Methods: Redox proteomics was used to identify oxidatively modified brain proteins in persons with mutations in the genes for presenilin - 1 (PS - 1). (content.iospress.com)
In January the Food and Drug Administration (FDA) approved Kalydeco, the first drug to treat people with a mutation of that gene. (discovermagazine.com)
People with that mutation do not use folic acid and should not eat enriched foods. (thyroidpharmacist.com)